ENDRA Life Sciences Inc.
NDRA
$4.87
$0.020.41%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -3.17M | -1.60M | -1.23M | -1.04M | -4.15M |
| Total Depreciation and Amortization | 39.50K | 39.40K | 32.80K | 45.60K | 46.40K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.55M | 412.00K | 26.70K | -325.50K | 2.38M |
| Change in Net Operating Assets | -33.80K | -19.40K | 52.80K | 23.10K | 211.10K |
| Cash from Operations | -1.61M | -1.16M | -1.11M | -1.29M | -1.52M |
| Capital Expenditure | 0.00 | 0.00 | 0.00 | -17.30K | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | 0.00 |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -3.00M | -- | -- | -- | -- |
| Cash from Investing | -3.00M | 0.00 | 0.00 | -17.30K | 0.00 |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | 0.00 |
| Issuance of Common Stock | 4.58M | 149.50K | 857.40K | 145.80K | 1.32M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -1.32M |
| Cash from Financing | 4.58M | 149.50K | 857.40K | 145.80K | 0.00 |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | 0.00 |
| Net Change in Cash | -31.70K | -1.01M | -256.30K | -1.16M | -1.52M |